Synopsis of recent research by authors named "Xinran Xi"
Recent research by Xinran Xi focuses on the mechanisms of cancer treatment resistance, particularly in gastric and lung cancers, highlighting the impact of mitochondrial function and related biomarkers on therapeutic efficacy.
One significant finding is that NPR1 plays a crucial role in cisplatin resistance in gastric cancer by inhibiting mitophagy and ferroptosis, suggesting potential therapeutic targets to overcome drug resistance.
Additionally, new nanotechnology approaches, such as the development of dual biomimetic delivery systems and novel temozolomide derivatives, demonstrate promising potential for enhancing cancer immunotherapy and overcoming drug resistance in glioma treatment.